Michael S. Anglesio
- Reproductive Medicine top 0.2%
- Ovarian cancer diagnosis and treatment 43
- Endometriosis Research and Treatment 14
- Obstetrics and Gynecology top 0.5%
- Endometrial and Cervical Cancer Treatments 22
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 7
-
- Cancer Mechanisms and Therapy 7
- Oncology top 5%
-
- Reproductive System and Pregnancy 12
-
- Chromatin Remodeling and Cancer 7
-
- Renal cell carcinoma treatment 6
- Co-authors
- David G. HuntsmanJanine SenzWinnie YangC. Blake GilksPaul J. YongJessica N. McAlpineMark CareyAline Talhouk
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Michael S. Anglesio
68 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Reproductive Medicine 1.8k
- Obstetrics and Gynecology 1.3k
- Cancer Research 737
- Pathology and Forensic Medicine 545
- Oncology 652
Countries citing papers authored by Michael S. Anglesio
This map shows the geographic impact of Michael S. Anglesio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Anglesio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Anglesio more than expected).
Fields of papers citing papers by Michael S. Anglesio
This network shows the impact of papers produced by Michael S. Anglesio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Anglesio. The network helps show where Michael S. Anglesio may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael S. Anglesio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 0 | |
| 5 | 2023 | 17 | |
| 6 | 2022 | 1 | |
| 7 | 2021 | 2 | |
| 8 | 2021 | 7 | |
| 9 | 2021 | 9 | |
| 10 | 2020 | 18 | |
| 11 | 2019 | 108 | |
| 12 | 2017 | 9 | |
| 13 | Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancerbreakdown → | 2017 | 631 |
| 14 | 2017 | 33 | |
| 15 | 2013 | 31 | |
| 16 | 2013 | 26 | |
| 17 | 2012 | 44 | |
| 18 | 2011 | 17 | |
| 19 | 2008 | 91 | |
| 20 | 2004 | 91 |
About Michael S. Anglesio
Michael S. Anglesio is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Cancer Research, Immunology and Pathology and Forensic Medicine, having authored 71 papers that have together received 3.6k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (43 papers), Endometrial and Cervical Cancer Treatments (22 papers), Endometriosis Research and Treatment (14 papers), Reproductive System and Pregnancy (12 papers), Cancer Mechanisms and Therapy (7 papers), Chromatin Remodeling and Cancer (7 papers), Cancer Genomics and Diagnostics (7 papers) and Renal cell carcinoma treatment (6 papers). The work is most often cited by research in Reproductive Medicine (1.8k citations), Obstetrics and Gynecology (1.3k citations), Cancer Research (737 citations), Pathology and Forensic Medicine (545 citations) and Oncology (652 citations). Michael S. Anglesio has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include David G. Huntsman, Janine Senz, Winnie Yang, C. Blake Gilks, Paul J. Yong, Jessica N. McAlpine, Mark Carey, Aline Talhouk, Samuel Leung and Martin Köbel. Their work appears in journals such as The Journal of Pathology, Clinical Cancer Research, PLoS ONE, Gynecologic Oncology and International Journal of Gynecological Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.